Funding for this research was provided by:
Chief Scientist Office, Scottish Government Health and Social Care Directorate (COV/GLA/20/03)
Received: 6 November 2020
Accepted: 11 November 2020
First Online: 19 November 2020
Ethics approval and consent to participate
: This trial has received ethical approval from the West of Scotland Research Ethics Service (WoSRES). This approval was granted on 20<sup>th</sup> May 2020 (REC reference: 20/WS/0073). Substantial amendments were approved by the same ethics committee on 28<sup>th</sup> July 2020 (REC reference: AM01) and 29<sup>th</sup> September 2020 (REC reference: AM03). Written informed consent to participation will be obtained from all patients recruited to the GETAFIX trial.
: Not applicable
: The authors have no conflicts of interest to declare.